This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Arthur J. Gallagher (AJG) Q1 Earnings Top on Margin Expansion
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q1 results reflect strong Brokerage and Risk Management segments, pricing increases and consistent primary insurance market conditions.
Arthur J. (AJG) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Arthur J.'s (AJG) first-quarter results are likely to reflect solid results in both segments aided by new business, strong retention and renewal premium increases across its business lines.
Marsh & McLennan (MMC) Q1 Earnings Beat on Segmental Strength
by Zacks Equity Research
Marsh & McLennan's (MMC) first-quarter results gain on strong contributions from international operations and the Consulting unit, partly offset by an elevated expense level.
Marsh & McLennan (MMC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 3.27% and 1.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Marsh & McLennan (MMC) Ahead of Earnings?
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Brown & Brown (BRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brown & Brown (BRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Marsh & McLennan (MMC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Focuses to Boost Hold in Australia
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer pursues twin growth-related initiatives to establish a solid hold on the superannuation market of Australia and expand its investment capabilities.
Arthur J. Gallagher (AJG) Closes Buck Buyout, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher (AJG) bought partnership interest in BCHR Holdings, L.P., dba Buck and its subsidiaries for $660 million to consolidate its portfolio of professional services.
Why Marsh & McLennan (MMC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Brown & Brown (BRO) Boosts Canada Presence With HBG Buyout
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Highcourt Partners is likely to provide it solid opportunities and a robust leadership team to boost growth in Canada.
Arthur J. Gallagher (AJG) Boosts Surety Market With Viking Bond
by Zacks Equity Research
The addition of Viking Bond Service to Arthur J. Gallagher's (AJG) portfolio is likely to enhance its existing surety offerings and boost its expertise in the surety market.
Aon (AON) Stock Jumps 4.6%: Will It Continue to Soar?
by Zacks Equity Research
Aon (AON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher and Ryan Specialty Holdings
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher and Ryan Specialty Holdings have been highlighted in this Industry Outlook article.
4 Insurance Brokers to Watch Despite Industry Challenges
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, AJG and RYAN.
Arthur J. Gallagher (AJG) Boosts Portfolio With Bay Risk
by Zacks Equity Research
The addition of Bay Risk to Arthur J. Gallagher's (AJG) portfolio is going to drive the expanding global programs practice of Gallagher Re.
After Plunging -7.66% in 4 Weeks, Here's Why the Trend Might Reverse for Marsh & McLennan (MMC)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Marsh & McLennan (MMC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AON Unit Launches New IP-Backed Lending Investment Vehicle
by Zacks Equity Research
AON unveils a new investment vehicle to help IT companies secure Intellectual Property backed funds.
Marsh & McLennan (MMC) Unit Buys Digital HR Firm Leapgen
by Zacks Equity Research
The Leapgen buyout is expected to enable Marsh & McLennan's (MMC) business, Mercer, to provide better HR digital solutions that can improve return on investment and utilization.
eHealth (EHTH) Q4 Earnings Top, Approved Members Fall Y/Y
by Zacks Equity Research
eHealth (EHTH) Q4 results reflect lower operating costs and expenses. However, revenues declined and so did approved members.
The Zacks Analyst Blog Highlights Apple, Linde, Marsh & McLennan Companies, GSK and Expedia
by Zacks Equity Research
Apple, Linde, Marsh & McLennan Companies, GSK and Expedia are included in this Analyst Blog.
Top Analyst Reports for Apple, Linde & Marsh & McLennan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Linde plc (LIN) and Marsh & McLennan Companies, Inc. (MMC).
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Factors That Make Marsh & McLennan (MMC) Stock A Lucrative Bet
by Zacks Equity Research
Marsh & McLennan (MMC) remains well-poised for growth on the back of solid contributions from business units. Strong cash-generating abilities is another tailwind for the stock.
Marsh & McLennan (MMC) Q4 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results reflect sound contributions from the Consulting segment and well-performing international operations, partly offset by escalating operating costs.